Clinical Trial Update: The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study [Phase 2]

View source ↗

Summary

A Phase 2 trial (DIGEST) evaluating efficacy, safety, and tolerability in gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Snippet

Sponsor: Theravance Biopharma | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED